The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Lessons Learned from a Patient with Rheumatoid Arthritis

Lessons Learned from a Patient with Rheumatoid Arthritis

June 1, 2014 • By Sarah Troxell, RN, BSN

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Rheumatoid Arthritis Patient Shares Lessons Learned from Breaking Leg in a Fall
  • A Short History of Rheumatoid Arthritis Therapeutics
  • Patient Fact Sheet: Rheumatoid Arthritis
Explore This Issue
June 2014
Also By This Author
  • Looking Back on 40 Years with Rheumatoid Arthritis
Lessons Learned
The author with her rheumatologist, Dr. Eric Gowing.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In summer 1978, I began to experience bilateral heel and ankle pain, along with morning stiffness and severe fatigue. I was a 25-year-old registered nurse at Mercy Medical Center in Oshkosh, Wis. As I made rounds with the doctors and carried their patient charts—yes, nurses did that back then—every step hurt. Results of blood work revealed the presence of a high-titer rheumatoid factor, a positive antinuclear antibody and an elevated erythrocyte sedimentation rate. X-rays of my hands demonstrated demineralization, and both elbow joints showed effusions (see Figure 1).

For the past 36 years, rheumatoid arthritis (RA) has been an integral part of my life and has taught me valuable lessons.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

click for large version
Figure 1: A 1979 X-ray report of the author’s hands, knees and elbows.

Lesson #1

The right medication is crucial.

Medication management is the foundation of successful RA treatment. I took 13 enteric-coated aspirin a day for the first year. This was useless; it was like trying to stop the Chicago fire with a wet handkerchief.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In 1979, I was referred to Madison, Wis., rheumatologist Robert Bonebrake, MD. Dr. Bonebrake recommended I start hydroxycholoroquine (HCQ). Soon, I began to feel amazingly better on this “magic medicine.”

After the HCQ stopped working in 1985, I was given gold injections, followed by oral gold.

I couldn’t tolerate sulfasalazine, so d-penicillamine was next. This made me feel better, but I lost my ability to taste sugar and salt. Potato chips tasted pretty flat. I continued on the drug until 1992, when my platelet count dropped to 85,000.

I was on azathioprine from 1993 to 2003, when I developed breast cancer.

At this time, the explosion of biologics had ushered in the promise of amazing relief. I began taking etanercept, which made me feel like a new person. I continued on it until 2014, when I began rituximab infusions, as prescribed by Eric Gowing, MD, my current rheumatologist. In addition, I took short courses of prednisone interspersed as bridge therapy throughout my RA treatment, as well as many nonsteroidal antiinflammatory drugs (NSAIDs).

Warnings of side effects accompanied many drugs, but I decided my quality of life was more important than if I lived to be 80 but felt miserable.

Lesson #2

An RA patient can live a meaningful life and have a wonderful family.

I have been blessed with my supportive husband Gary, who is a medical technologist.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Profiles, Rheumatoid Arthritis Tagged With: Antiphospholipid Antibody Syndrome (APS), Association of Rheumatology Professionals (ARP), Biologics, Hughes Syndrome, Methotrexate, prednisone, Profile, RA, Rheumatoid arthritis, rheumatologist, rituximab, TroxellIssue: June 2014

You Might Also Like:
  • Rheumatoid Arthritis Patient Shares Lessons Learned from Breaking Leg in a Fall
  • A Short History of Rheumatoid Arthritis Therapeutics
  • Patient Fact Sheet: Rheumatoid Arthritis
  • Lessons Learned from Two Scleroderma Lung Studies (Plus a Third That’s Recruiting Sites)

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)